Company Filing History:
Years Active: 2025
Title: Innovations in Pathogen Detection by Shan Liang
Introduction
Shan Liang is a notable inventor based in Chengdu, China. He has made significant contributions to the field of molecular biology, particularly in the detection of pathogens in transplant patients. His work is crucial for improving patient outcomes and enhancing the safety of transplant procedures.
Latest Patents
Shan Liang holds a patent for "Primer and probe sets for pathogen detection of infection in transplant patient, kit and use thereof." This patent relates to a set of primer and probe combinations designed for the detection of infections in transplant patients. The technology encompasses 23 primer and probe sets that can jointly detect 23 different pathogens known for their high infection and lethality rates post-transplantation. Notably, this includes adenovirus type B. Each probe in the set is equipped with a fluorophore and a quencher group, enabling precise detection. Additionally, the patent includes a real-time fluorescence quantitative PCR kit that facilitates simultaneous detection of these pathogens, which is vital for timely medical intervention.
Career Highlights
Shan Liang is affiliated with the Chinese Academy of Medical Sciences, where he continues to advance research in medical diagnostics. His innovative work has positioned him as a key figure in the field of pathogen detection, particularly in the context of organ transplantation.
Collaborations
Shan Liang collaborates with Miao He, contributing to the development of advanced diagnostic tools that enhance patient care in transplant medicine.
Conclusion
Shan Liang's contributions to pathogen detection represent a significant advancement in medical technology. His innovative patent not only aids in the early detection of infections but also plays a critical role in improving the safety and efficacy of transplant procedures.